Seon-Hwa Baek

Dr. Seon-Hwa Baek

Chonnam National University Hospital, Gwangju, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SBSeon-Hwa Baek
Seon-Hwa Baek
HKHoney Kim
Honey Kim
Sung-Wan KimSung-Wan Kim
Sung-Wan Kim
SRSeunghyong Ryu
Seunghyong Ryu
JLJu-Yeon Lee
Ju-Yeon Lee
Sung-Wan KimSung-Wan Kim
Sung-Wan Kim
In this study, we investigated the impact of inflammatory cytokines on the cognitive performance of patients with schizophrenia. The included patients met the criteria for schizophrenia spectrum disorder and were aged between 15 and 40 years, with a duration of illness ≤1 year. Plasma tumor necrosis factor (TNF)-α; interferon-γ; and interleukin (IL)-1β, IL-6, IL-8, IL-10, and IL-12 levels were measured. A computerized neurocognitive battery, measures for social cognitive function, and clinical measures were administered. A total of 174 patients with first-episode psychosis were enrolled. The TNF-α level was negatively correlated with scores on the digit span, verbal learning, and Wisconsin card sorting tests, and the number of correct responses on the continuous performance test (CR-CPT), whereas a positive correlation was detected with the trail making test (TMT)-B time. The interferon-γ level was negatively correlated with performance on the false belief and visual learning tests. The IL-1β level was positively correlated with the TMT-A time and CPT reaction time, whereas it was negatively correlated with the CR-CPT and performance on the visual learning and social cognitive tests. The IL-12 level was negatively correlated with the CR-CPT and false belief test. Our results suggest that proinflammatory cytokines are associated with cognitive impairment in patients with schizophrenia.

28 February 2022 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
SRSeunghyong Ryu
Seunghyong Ryu
HNHee Jung Nam
Hee Jung Nam
SBSeon-Hwa Baek
Seon-Hwa Baek
MJMin Jhon
Min Jhon
JKJae-Min Kim
Jae-Min Kim
Sung-Wan KimSung-Wan Kim
Sung-Wan Kim
Seunghyong Ryu, Hee Jung Nam, Seon-Hwa Baek, Min Jhon, Jae-Min Kim, Sung-Wan Kim. Clin Psychopharmacol Neurosci 2022;20:185-9. https://doi.org/10.9758/cpn.2022.20.1.185

1 January 2025 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SRSeunghyong Ryu
Seunghyong Ryu
SBSeon-Hwa Baek
Seon-Hwa Baek
MJMin Jhon
Min Jhon
HKHoney Kim
Honey Kim
JLJu-Yeon Lee
Ju-Yeon Lee
Sung-Wan KimSung-Wan Kim
Sung-Wan Kim
Ryu S, et al. J Korean Med Sci. 2025 Jan;40:e59. https://doi.org/10.3346/jkms.2025.40.e59

10 February 2024 in Journal of the Korean Medical Association
Verified
Journal Article
Open access
PDF file
Sung-Wan KimSung-Wan Kim
Sung-Wan Kim
SBSeon-Hwa Baek
Seon-Hwa Baek
CCChul-Hyun Cho
Chul-Hyun Cho
Background: Schizophrenia is a severe mental disorder that significantly impairs the daily functioning of patients that causes substantial societal and economic burden. While drug therapy is crucial for schizophrenia treatment, relying solely on antipsychotic drugs does not yield the most favorable therapeutic outcomes.Current Concepts: Integrating psychosocial interventions could result in maximized therapeutic effects for individuals living with schizophrenia. Evidence-based psychosocial interventions for schizophrenia management include cognitive behavioral therapy, family involvement, psychoeducation, supported employment programs, lifestyle adjustments for physical health, and coordinated and comprehensive early intervention services. Incorporating peer support, allowing both service users and care providers to share knowledge and their illnessrelated personal experiences, facilitates mutual assistance along the path to recovery. Moreover, growing interest follows in using digital interventions, such as wearable technology and smartphone applications, as effective therapeutic tools for illness management.Discussion and Conclusion: The above-mentioned psychosocial interventions empower individuals with schizophrenia, helping them improve their functioning, enhance their life quality, and adapt more effectively to society. Combining early medication with comprehensive psychosocial interventions, including digital technology, is crucial for the best outcomes. This approach should begin as soon as schizophrenia is diagnosed, aiming to promote recovery and overall well-being in affected individuals.

18 November 2022 in Frontiers in Psychiatry
Verified
Journal Article
Open access
SBSeon-Hwa Baek
Seon-Hwa Baek
JKJu-Wan Kim
Ju-Wan Kim
YLYun Young Lee
Yun Young Lee
JKJu-Yong Kim
Ju-Yong Kim
Sung-Wan KimSung-Wan Kim
Sung-Wan Kim
JKJae-Min Kim
Jae-Min Kim
Objectives: This report aims to introduce a rare case of a dramatic recovery by donepezil with a patient with schizophrenia who suffered from remaining psychotic symptoms despite proper treatment and had a cognitive impairment by carbon monoxide (CO) poisoning sequelae.Case report: A 38-year-old male who developed schizophrenia 2 years ago had attempted suicide via CO inhalation due to his uncontrolled symptoms. He was hospitalized with delayed neurological sequelae (DNS). Though hyperbaric oxygen therapy (HBOT) was applied 10 times, his cognitive impairment did not recover. Surprisingly, with 5–10 mg donepezil, both cognitive function and the psychotic symptoms of the patient remarkably improved.Conclusion: This case showed a good response of donepezil for a patient with schizophrenia and CO-induced DNS after ineffective HBOT. Although the mechanism of the phenomenon is unclear, it can be possible reasons that the neuroprotective effect of donepezil and white matter insult by CO poisoning.

1 January 2024 in Journal of Korean Neuropsychiatric Association
Verified
Journal Article
Open access
PDF file
SRSeunghyong Ryu
Seunghyong Ryu
SBSeon-Hwa Baek
Seon-Hwa Baek
MJMin Jhon
Min Jhon
HKHoney Kim
Honey Kim
JLJu-Yeon Lee
Ju-Yeon Lee
Sung-Wan KimSung-Wan Kim
Sung-Wan Kim
유승형, et al. J Korean Neuropsychiatr Assoc. 2024 Nov;63(4):237-245. https://doi.org/10.4306/jknpa.2024.63.4.237